2001PubMedRequires access

[Medetomidine-butorphanol combination anesthesia in the dog].

K Güller, André Busato, Mirjam Lang, H Boschung

Open publisher page 1 citations

Abstract

The combination of Medetomidine and Butorphanol leads to a sufficient sedation with good analgesia and is thus superior to the application of Medetomidine only. By reducing the dosage of Medetomidine, reduced cardio-respiratory side-effects are to be expected. The comparative application of the two Butorphanol preparations Torbugesic (group T) and Morphasol (group M) did not show any differences concerning effect and tolerance. No statistically significant and clinically relevant differences between the two groups were observed for any of the parameters.

About this research paper

What this paper is about

The combination of Medetomidine and Butorphanol leads to a sufficient sedation with good analgesia and is thus superior to the application of Medetomidine only. By reducing the dosage of Medetomidine, reduced cardio-respiratory side-effects are to be expected. The comparative application of the two Butorphanol preparations Torbugesic (group T) and Morphasol (group M) did not show any differences concerning effect and tolerance. No statistically significant and clinically relevant differences between the two groups were observed for any of the parameters.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The combination of Medetomidine and Butorphanol leads to a sufficient sedation with good analgesia and is thus superior to the application of Medetomidine only. By reducing the dosage of Medetomidine, reduced cardio-respiratory side-effects are to be expected. The comparative application of the two Butorphanol preparations Torbugesic (group T) and Morphasol (group M) did not show any differences concerning effect and tolerance. No statistically significant and clinically relevant differences between the two groups were observed for any of the parameters.

Key concepts: Butorphanol, Medetomidine, Sedation, Medicine, Anesthesia, Respiratory system, Internal medicine, Heart rate

Related papers

Back to paper searchBrowse research topicsOriginal source
[Medetomidine-butorphanol combination anesthesia in the dog]. — Research Paper | ScholarLens